Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients
Sponsor: Xiaotong Hou
Summary
The goal of this observational study is to learn about the association between vasopressor exposure levels and outcomes in adults with cardiogenic shock receiving VA-ECMO. The main question it aims to answer is: Does reduced exposure to vasopressors lower the 30-day mortality in patients with cardiogenic shock when receiving ECMO support? Participants who are receiving ECMO support for cardiogenic shock as part of their regular medical care will have their data collected, including information about their vasopressor use and mortality outcomes, over the course of the study.
Official title: Association Between Vasopressor Exposure Levels and 30-Day Mortality in Patients Receiving ECMO Support for Cardiogenic Shock: A Prospective Multicenter Cohort Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
534
Start Date
2025-02-26
Completion Date
2028-01-01
Last Updated
2025-03-06
Healthy Volunteers
No
Conditions
Interventions
Vasopressor Exposure Levels
This is an observational study with no active intervention. The study evaluates the association between natural variations in vasopressor exposure levels (measured by Vasoactive-Inotropic Score, VIS) and clinical outcomes in patients receiving VA-ECMO for cardiogenic shock.
Locations (1)
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China